All locations

See a listing of all our Children’s Hospital Colorado locations including inpatient, outpatient, therapy, surgery facilities and more.

Locations near you

See all locations

Bradford Siegele, MD, JD

Provider's Specialties

Pathology
Hematology/Oncology
Pathology - Pediatric

Provider's location(s)

Anschutz Medical Campus, Aurora

View map

Patient ratings

Patient ratings and reviews are not available

Why?

Pathology and Laboratory Services

(720)777-6714

Insurance plans accepted

We participate with most major health insurance plans and national transplant networks.

View the full list

Prepare for your visit

We want to make sure you know what to expect before you arrive.

See the checklist

Get to know Bradford Siegele, MD, JD

Departments and Programs

Conditions Treated

Leukemia (Adult Acute)
Leukemia (Adult Chronic)
Leukemia
Leukemia

Hodgkin Lymphoma in Children
Myelodysplastic Syndrome
Myeloma
Pediatric Cancer
Sarcoma
Cancer Pathology
Bone Marrow Failure
Pediatric Diseases and Conditions
Teen Health

Languages spoken

English
Spanish
French
German

Experience and background

My research interests are primarily focused on characterizing and investigating tools for diagnosis of pediatric, adolescent/young adult, and adult leukemias and lymphomas.

Undergraduate 1999

Duke University (NC)

Graduate 2005

Harvard University

Medical Education 2012

University of Texas Southwestern Medical Center at Dallas Southwestern Medical School

Residency 2016

University of Colorado (University Hospital) Program

Fellowship 2017

Dana-Farber Cancer Institute/Boston Children’s Hospital/Harvard Medical School Program

Fellowship 2018

Massachusetts General Hospital Program

For Patients:
My research interests are primarily focused on characterizing and investigating tools for diagnosis of pediatric, adolescent/young adult, and adult leukemias and lymphomas.

For Referring Providers:
My research interests are primarily focused on characterizing and investigating tools for diagnosis of pediatric, adolescent/young adult, and adult leukemias and lymphomas, with a special emphasis on emerging diseases including DUX4-IgG translocated ALL, Ph-like ALL, pediatric MDS, and myeloid neoplasms with germline predisposition.